Raymond James & Associates’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-32,600
Closed -$13K 4194
2021
Q3
$13K Buy
32,600
+2,800
+9% +$22.2K ﹤0.01% 4040
2021
Q2
$7K Buy
29,800
+14,500
+95% +$117K ﹤0.01% 4040
2021
Q1
$2K Buy
+15,300
New +$105K ﹤0.01% 3979
2020
Q4
Sell
-48,900
Closed -$5K 3808
2020
Q3
$5K Sell
48,900
-1,200
-2% -$9.2K ﹤0.01% 3558
2020
Q2
$5K Buy
50,100
+8,600
+21% +$73K ﹤0.01% 3500
2020
Q1
$32K Sell
41,500
-5,200
-11% -$48.5K ﹤0.01% 3359
2019
Q4
$70K Buy
46,700
+7,700
+20% +$83.9K ﹤0.01% 3518
2019
Q3
$33K Buy
39,000
+300
+0.8% +$2.42K ﹤0.01% 3505
2019
Q2
$5K Buy
+38,700
New +$308K ﹤0.01% 3609
2016
Q4
Sell
-11,700
Closed -$1K 3287
2016
Q3
$1K Buy
+11,700
New +$90.4K ﹤0.01% 3206

Other funds holding FRO

Raymond James & Associates's FRO Position: Q3 2024 in Review

Raymond James & Associates reduced its Frontline (FRO) stake by 49% in Q3 2024, selling an estimated $386K and leaving 17,293 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #3244.

Raymond James & Associates first reported a position in FRO in Q2 2013 and has held it in 44 quarters since. The position peaked at $868K in Q2 2024. 170 funds tracked by Wall St. Rank hold FRO as of Q3 2024.

  • Raymond James & Associates held 17,293 shares of Frontline worth $395K as of Q3 2024.
  • Raymond James & Associates sold 16,414 Frontline shares in Q3 2024, an estimated $386K.
  • Frontline made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3244 holding.
  • Raymond James & Associates first reported a position in Frontline in Q2 2013 and has held it in 44 quarters since.
  • Raymond James & Associates's Frontline position peaked at $868K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Frontline as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.